Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
bcl-2-Associated X Protein | 7 | 2014 | 111 | 1.090 |
Why?
|
Apoptosis | 7 | 2015 | 1641 | 1.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2005 | 174 | 0.730 |
Why?
|
Antibodies, Monoclonal | 3 | 2005 | 511 | 0.580 |
Why?
|
Ceramides | 3 | 2009 | 578 | 0.510 |
Why?
|
Mitochondria | 6 | 2014 | 643 | 0.500 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 71 | 0.480 |
Why?
|
Photochemotherapy | 1 | 2015 | 59 | 0.480 |
Why?
|
RNA Interference | 1 | 2015 | 266 | 0.460 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 434 | 0.430 |
Why?
|
Genetic Therapy | 1 | 2015 | 291 | 0.430 |
Why?
|
Mouth Neoplasms | 1 | 2015 | 206 | 0.420 |
Why?
|
Nanoparticles | 1 | 2015 | 254 | 0.390 |
Why?
|
Mitochondrial Proteins | 2 | 2008 | 113 | 0.370 |
Why?
|
Sphingomyelins | 2 | 2008 | 106 | 0.370 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 629 | 0.340 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2009 | 48 | 0.330 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 561 | 0.330 |
Why?
|
Cytochromes c | 3 | 2008 | 75 | 0.320 |
Why?
|
Second Messenger Systems | 1 | 2008 | 53 | 0.320 |
Why?
|
Pyrazoles | 1 | 2009 | 190 | 0.310 |
Why?
|
Pyrimidines | 1 | 2009 | 178 | 0.310 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 498 | 0.300 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 204 | 0.280 |
Why?
|
Membrane Proteins | 2 | 2010 | 617 | 0.280 |
Why?
|
Transcriptional Activation | 1 | 2007 | 226 | 0.270 |
Why?
|
Cell Line, Tumor | 5 | 2015 | 1851 | 0.270 |
Why?
|
Cell Proliferation | 4 | 2015 | 1174 | 0.260 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 756 | 0.260 |
Why?
|
Epithelial Cells | 2 | 2005 | 431 | 0.250 |
Why?
|
COS Cells | 4 | 2007 | 155 | 0.250 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2005 | 300 | 0.240 |
Why?
|
Antigens, Surface | 1 | 2004 | 71 | 0.230 |
Why?
|
ErbB Receptors | 1 | 2005 | 239 | 0.230 |
Why?
|
Protein Transport | 4 | 2009 | 280 | 0.230 |
Why?
|
Proto-Oncogene Proteins | 2 | 2010 | 411 | 0.210 |
Why?
|
Carrier Proteins | 1 | 2005 | 597 | 0.210 |
Why?
|
bcl-X Protein | 3 | 2007 | 36 | 0.190 |
Why?
|
Cytoplasm | 2 | 2014 | 155 | 0.190 |
Why?
|
Breast Neoplasms | 1 | 2009 | 1536 | 0.170 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2010 | 102 | 0.160 |
Why?
|
Animals | 9 | 2015 | 20881 | 0.160 |
Why?
|
Sphingosine N-Acyltransferase | 2 | 2009 | 62 | 0.160 |
Why?
|
Oxidoreductases | 2 | 2009 | 117 | 0.160 |
Why?
|
Serpins | 2 | 2010 | 205 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2010 | 331 | 0.150 |
Why?
|
Endothelium, Vascular | 2 | 2010 | 371 | 0.150 |
Why?
|
Cell Line | 3 | 2010 | 1752 | 0.140 |
Why?
|
Up-Regulation | 2 | 2010 | 682 | 0.140 |
Why?
|
Mice | 4 | 2015 | 8474 | 0.130 |
Why?
|
Protein Structure, Tertiary | 2 | 2007 | 322 | 0.130 |
Why?
|
Receptors, sigma | 1 | 2015 | 6 | 0.130 |
Why?
|
Humans | 12 | 2015 | 68618 | 0.120 |
Why?
|
Tumor Burden | 1 | 2015 | 132 | 0.120 |
Why?
|
Basal Ganglia | 1 | 2014 | 45 | 0.120 |
Why?
|
Mice, Nude | 1 | 2015 | 294 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 304 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2014 | 97 | 0.110 |
Why?
|
Sulfonamides | 1 | 2014 | 141 | 0.110 |
Why?
|
Transfection | 1 | 2015 | 782 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 231 | 0.110 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 951 | 0.100 |
Why?
|
Cell Survival | 1 | 2014 | 901 | 0.100 |
Why?
|
NF-kappa B | 2 | 2010 | 432 | 0.090 |
Why?
|
Signal Transduction | 2 | 2010 | 2689 | 0.090 |
Why?
|
Claudin-1 | 1 | 2010 | 3 | 0.090 |
Why?
|
Culture Media, Serum-Free | 1 | 2010 | 35 | 0.090 |
Why?
|
Oxidative Stress | 2 | 2014 | 718 | 0.090 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2010 | 10 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2010 | 626 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2009 | 25 | 0.090 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2010 | 77 | 0.090 |
Why?
|
Fluorouracil | 1 | 2010 | 130 | 0.090 |
Why?
|
Cadherins | 1 | 2010 | 93 | 0.090 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 200 | 0.090 |
Why?
|
Sphingomyelin Phosphodiesterase | 2 | 2008 | 183 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 337 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 320 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 282 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 710 | 0.080 |
Why?
|
Aging | 1 | 2014 | 911 | 0.080 |
Why?
|
Cell Hypoxia | 1 | 2008 | 92 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 492 | 0.080 |
Why?
|
Rats | 3 | 2010 | 5300 | 0.080 |
Why?
|
Blotting, Western | 1 | 2010 | 954 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 332 | 0.070 |
Why?
|
Leucine | 1 | 2007 | 41 | 0.070 |
Why?
|
Cytosol | 1 | 2007 | 123 | 0.070 |
Why?
|
Point Mutation | 1 | 2007 | 97 | 0.070 |
Why?
|
Aspartic Acid | 1 | 2007 | 65 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 137 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2007 | 231 | 0.070 |
Why?
|
Time Factors | 1 | 2015 | 4655 | 0.070 |
Why?
|
Staurosporine | 1 | 2005 | 19 | 0.070 |
Why?
|
bcl-Associated Death Protein | 1 | 2005 | 19 | 0.070 |
Why?
|
Glycoside Hydrolases | 1 | 2005 | 25 | 0.070 |
Why?
|
Glycosylation | 1 | 2005 | 185 | 0.060 |
Why?
|
HeLa Cells | 1 | 2004 | 237 | 0.060 |
Why?
|
Genes, Reporter | 1 | 2003 | 191 | 0.060 |
Why?
|
Hybridomas | 1 | 2003 | 25 | 0.060 |
Why?
|
Caspases | 1 | 2003 | 194 | 0.060 |
Why?
|
Mutation | 2 | 2005 | 1213 | 0.060 |
Why?
|
Precipitin Tests | 1 | 2003 | 88 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2004 | 284 | 0.050 |
Why?
|
Female | 3 | 2015 | 38074 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 507 | 0.050 |
Why?
|
Species Specificity | 1 | 2003 | 303 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2004 | 852 | 0.050 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 189 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 532 | 0.050 |
Why?
|
Rats, Wistar | 2 | 2014 | 371 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 1293 | 0.050 |
Why?
|
Reactive Oxygen Species | 2 | 2014 | 499 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2014 | 93 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 130 | 0.030 |
Why?
|
In Vitro Techniques | 1 | 2014 | 765 | 0.030 |
Why?
|
Homeostasis | 1 | 2014 | 291 | 0.030 |
Why?
|
Glutathione | 1 | 2014 | 343 | 0.030 |
Why?
|
Phosphorylation | 1 | 2014 | 1200 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 332 | 0.020 |
Why?
|
Bcl-2-Like Protein 11 | 1 | 2010 | 11 | 0.020 |
Why?
|
NADP | 1 | 2010 | 39 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2010 | 100 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2010 | 94 | 0.020 |
Why?
|
Gene Library | 1 | 2009 | 68 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2009 | 45 | 0.020 |
Why?
|
Age Factors | 1 | 2014 | 1864 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2009 | 101 | 0.020 |
Why?
|
Models, Animal | 1 | 2010 | 252 | 0.020 |
Why?
|
Vascular Diseases | 1 | 2009 | 94 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2009 | 196 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 290 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2010 | 382 | 0.020 |
Why?
|
Cell Membrane | 1 | 2009 | 525 | 0.020 |
Why?
|
Protein Binding | 1 | 2009 | 1027 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 659 | 0.020 |
Why?
|
Cell-Free System | 1 | 2005 | 43 | 0.020 |
Why?
|
Cell Death | 1 | 2005 | 329 | 0.010 |
Why?
|
Myocardium | 1 | 2009 | 1204 | 0.010 |
Why?
|
Inflammation | 1 | 2009 | 1030 | 0.010 |
Why?
|
Male | 1 | 2010 | 37321 | 0.000 |
Why?
|